Search

Your search keyword '"Pasqualetti, F"' showing total 430 results

Search Constraints

Start Over You searched for: Author "Pasqualetti, F" Remove constraint Author: "Pasqualetti, F"
430 results on '"Pasqualetti, F"'

Search Results

201. Uncovering the biological basis of control energy: Structural and metabolic correlates of energy inefficiency in temporal lobe epilepsy.

202. New perspectives in liquid biopsy for glioma patients.

203. Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early.

204. Functional control of oscillator networks.

205. Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.

206. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients.

207. Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.

208. Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.

209. Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation.

210. Integrating stereotactic radiotherapy and systemic therapies.

211. Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.

212. Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

213. Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background.

214. Stereotactic radiotherapy for oligometastases in the lymph nodes.

215. Stereotactic radiotherapy for bone oligometastases.

216. Path-dependent dynamics induced by rewiring networks of inertial oscillators.

217. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.

218. Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature.

219. Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO.

220. Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial).

221. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.

223. Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy.

224. Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia.

225. Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary History.

226. Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.

227. Data-driven control of complex networks.

228. Time-evolving controllability of effective connectivity networks during seizure progression.

229. Brain network dynamics fingerprints are resilient to data heterogeneity.

230. Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO).

231. Radiotherapy in the COVID-19 Pandemic Era.

232. Path-dependent connectivity, not modularity, consistently predicts controllability of structural brain networks.

233. Models of communication and control for brain networks: distinctions, convergence, and future outlook.

234. Clinical Management of Diffuse Low-Grade Gliomas.

235. Gene coexpression patterns predict opiate-induced brain-state transitions.

236. Learning in brain-computer interface control evidenced by joint decomposition of brain and behavior.

237. Control of brain network dynamics across diverse scales of space and time.

238. Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?

239. A practical guide to methodological considerations in the controllability of structural brain networks.

240. Optimization of energy state transition trajectory supports the development of executive function during youth.

241. Fragility Limits Performance in Complex Networks.

242. Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review".

243. Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.

244. Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.

245. White Matter Network Architecture Guides Direct Electrical Stimulation through Optimal State Transitions.

246. RE: Warnings and caveats in brain controllability.

247. Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues.

248. Definitive radiotherapy for recurrent vulvar carcinoma after primary surgery: a two-institutional Italian experience.

249. A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?

250. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Catalog

Books, media, physical & digital resources